Fig. 9From: Theranostic RGD@Fe3O4-Au/Gd NPs for the targeted radiotherapy and MR imaging of breast cancerROS test results in MDA-MB-231 cells for A blank group, B negative control group, C positive control group, D Fe3O4-Au/Gd group, E RGD@Fe3O4-Au/Gd group, E radiotherapy group, G Fe3O4-Au/Gd + radiotherapy group and H RGD@Fe3O4-Au/Gd + radiotherapy group. The dose of radiotherapy was 2 Gy and the concentration of the NPs was 0.05 mMBack to article page